Financials
Financial year 2025
VDS PHARMA from Sint-Pieters-Leeuw, company number BE0597740922, closed financial year 2025 with a result of € 74,668 after tax. For that financial year VDS PHARMA recorded a gross margin of € 106,828 and equity of € 502,844. Compared with financial year 2024, the result moved from € 17,244 to € 74,668. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.
€ 502,844
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 74,668
▲ € 57,424 vs 2024
Profit after tax over the fiscal year.
€ 23,878
▲ 199% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 21,176 paid out
28 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 228,409
▼ 15% vs 2024
€ 51,731 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 2,792
▼ 57% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,488
▲ 1% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 128,782 | € 127,415 | € 36,307 | € 106,828 | ▲ 194% |
| Profit after taxes | € 97,686 | € 91,429 | € 17,244 | € 74,668 | ▲ € 57,424 |
| Equity | € 373,328 | € 447,107 | € 449,351 | € 502,844 | ▲ 12% |
| Total debts | € 479,603 | € 443,424 | € 384,409 | € 318,876 | ▼ 17% |
| Cash | € 10,999 | € 11,604 | € 7,981 | € 23,878 | ▲ 199% |
| Retained profit | € 354,728 | € 428,507 | € 430,751 | € 484,244 | ▲ 12% |
| Dividend | € 20,000 | € 17,650 | € 15,000 | € 21,176 | ▲ 41% |
| Bank debt | € 408,685 | € 343,559 | € 268,438 | € 228,409 | ▼ 15% |
| Balance sheet total | € 852,931 | € 890,532 | € 833,761 | € 821,719 | ▼ 1% |
Key figures of VDS PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to VDS PHARMA?
What happened at VDS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 74,668 (▲ € 57,424 vs 2024). Source: NBB ↗
- New establishment in Sint-Pieters-Leeuw. KBO
- Zoë Vandersteen became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 97,686 profit in 2022 to € 74,668 profit in 2025.
Paid € 74,183 in corporate taxes since 2022.
Best year ever: 2022, with € 97,686 profit.
Paid out € 73,826 in dividends to the owners in total.
A new publication or filing at VDS PHARMA? We notify you, reason included.
Follow VDS PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VDS PHARMA is Zoë Vandersteen. Zoë Vandersteen is also behind APOTHEEK VANDERSTEEN.
Directors
According to the 2025 annual accounts
since 2015
Establishments
Establishment units
Physical locations of this company
Zuundallaan 22
1600 Sint-Pieters-Leeuw
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0597.740.922
- VAT number
- BE 0597.740.922
- Registered office
- Zuundallaan 22, 1600 Sint-Pieters-Leeuw
- Names & denominations
- VDS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 February 2015
- Peppol
- Active · Active since 25 Sept 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering